Cancer Management and Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2025-07-14 旧喜来自江苏省

反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了
经验分享：Received: 17 August 2024
Accepted: 11 December 2024
Published: 27 December 2024

89 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2025-03-11 ms7000000032128045 来自重庆

请问这个期刊接不接受case啊

99 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2024-11-06 sci20210526 来自江苏省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：可以快速accept

201 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2024-06-22 侠胆医心来自威斯康星

审稿速度:6.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;慢病管理;肿瘤康复
经验分享：2023年度影响因子为2.5分

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2024-04-30 ms1000001446944017 来自山东省

真的好慢啊，反复要原始数据

933 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2023-12-13 秋思来自广东省

记录一下：
23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a

978 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2024-04-10 ms3000000420360328 来自浙江省

跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。

935 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2024-03-13 weichusci01 来自广西

周期也就两三个月

942 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2021-10-21 Doctor Xu

审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0
偏重的研究方向：肿瘤学;淋巴瘤
经验分享：投稿时间：18/Aug/2021
审稿返回：2021.9.13
接受：2021.10.15
On-line出版时间：21/Oct/2021

0 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2273293, encodeId=980922e3293c6, content=反馈都比较快的一本杂志，8月投递的，12月底在线，不过就是有五个审稿人，太认真了 经验分享：Received: 17 August 2024 Accepted: 11 December 2024 Published: 27 December 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/7184D5A73183D553B3C5EF64FAA03D5F/100, createdBy=8f3c2428741, createdName=旧喜, createdTime=Mon Jul 14 12:30:39 CST 2025, time=2025-07-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2255611, encodeId=9f092255611f2, content=请问这个期刊接不接受case啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af6a8368334, createdName=ms7000000032128045, createdTime=Tue Mar 11 13:16:09 CST 2025, time=2025-03-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235597, encodeId=cc8f223559ec5, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：可以快速accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=260b9504965, createdName=sci20210526, createdTime=Wed Nov 06 22:17:07 CST 2024, time=2024-11-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211106, encodeId=3703221110668, content=审稿速度:6.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;慢病管理;肿瘤康复 经验分享：2023年度影响因子为2.5分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:55:20 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2201206, encodeId=fdb722012064c, content=真的好慢啊，反复要原始数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=933, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d8514465, createdName=ms1000001446944017, createdTime=Tue Apr 30 10:08:27 CST 2024, time=2024-04-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2174772, encodeId=7da221e4772f9, content=记录一下： 23.11.27投稿 1A; 11.30 1ab; 12.02 1e; 12.06 收到邮件解释动物伦理问题并上传伦理批件； 12.08 1f; 12.11 又变成1e，收到邮件说提供WB原始图； 12.12 1f; 12.13 2a , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=978, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Wed Dec 13 18:07:24 CST 2023, time=2023-12-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2197766, encodeId=bca8219e766bf, content=跟共同作者联系不方便的慎投，经常要给每个作者发邮件，需要每个作者确认。而且3周了还在初审，找审稿人也巨慢，投另一个杂志ONCOtarget and therapy的时候经过一个半月没找到审稿人退回了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=935, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed Apr 10 15:59:10 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2192990, encodeId=39982192990c9, content=周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=942, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/47914c6997134a928ed954f7a8071140-N1SdjCB9k2Cx.jpg, createdBy=0fcc9212232, createdName=weichusci01, createdTime=Wed Mar 13 16:46:07 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1062688, encodeId=4040106268899, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2750.0 偏重的研究方向：肿瘤学;淋巴瘤 经验分享：投稿时间：18/Aug/2021 审稿返回：2021.9.13 接受：2021.10.15 On-line出版时间：21/Oct/2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8e32007663, createdName=Doctor Xu, createdTime=Thu Oct 21 20:20:00 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568257, encodeId=250856825e05, content=我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, beContent=xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1083, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab612479180, createdName=124544f0m58暂无昵称, createdTime=Mon Mar 18 00:00:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-03-18 124544f0m58暂无昵称

我的文章是用了一个多月的时间才找到审稿人。但是审稿速度很快，两周内意见就回来了？xinqq1017 2019-03-18 00:00:00 发表:
一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？

xinqq1017 2019-03-18 00:00:00 发表: 一审多少时间啊？我都投稿6周了还是只找到一个审稿人，要不要催稿呢？

1083 5 举报

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务